NDC 51655-809 – Ondansetron

Ondansetron 8 mg/1 · Tablet, Orally Disintegrating · Oral

Human Prescription Drug

Product NDC51655-809

Product details

Brand name
Ondansetron
Generic name
Ondansetron
Labeler
Northwind Health Company, LLC
Dosage form
Tablet, Orally Disintegrating
Route
Oral
Marketing category
ANDA · ANDA090469
Marketed since
November 30, 2020
Listing expires
December 31, 2027
Pharmacologic class
Serotonin-3 Receptor Antagonist

Active ingredients

Uses, dosage, side effects and warnings for Ondansetron →

Package NDC codes (3)

Package NDCDescriptionSince
51655-809-044 TABLET, ORALLY DISINTEGRATING in 1 BAG (51655-809-04)Nov 7, 2022
51655-809-5310 TABLET, ORALLY DISINTEGRATING in 1 BAG (51655-809-53)May 6, 2022
51655-809-876 TABLET, ORALLY DISINTEGRATING in 1 BAG (51655-809-87)Nov 30, 2020

Other Ondansetron products